The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma
Background/Aims Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. We aimed to determine the effect of COVID-19 countermeasures on treatment...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
The Korean Association of Internal Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/baa0bf3f9f8840cba3280b086bacb16c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:baa0bf3f9f8840cba3280b086bacb16c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:baa0bf3f9f8840cba3280b086bacb16c2021-11-08T00:59:06ZThe effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma1226-33032005-664810.3904/kjim.2021.186https://doaj.org/article/baa0bf3f9f8840cba3280b086bacb16c2021-11-01T00:00:00Zhttp://www.kjim.org/upload/pdf/kjim-2021-186.pdfhttps://doaj.org/toc/1226-3303https://doaj.org/toc/2005-6648Background/Aims Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. We aimed to determine the effect of COVID-19 countermeasures on treatment outcomes in this patient population. Methods We retrospectively analyzed data on patients treated for lymphoma or multiple myeloma in two tertiary hospitals in Seoul. Patients were divided into two groups: group 1 included patients who received chemotherapy between September and December 2019 (the control period), and group 2 included patients who received chemotherapy between September and December 2020 (the study period). Countermeasures to COVID-19 were applied to the patients in group 2. The countermeasures implemented included mask wearing and regular handwashing at home and in hospital; COVID-19 risk assessments on all hospital visitors; and pre-emptive COVID-19 screening for all newly hospitalized patients and their resident guardians. Results No differences in treatment outcomes, including treatment response, incidence and duration of neutropenia or neutropenic fever, delays in chemotherapy, or number of deaths during chemotherapy, were observed between the g roups. None of the patients in group 2 tested positive for COVID-19, and there were no COVID-19-related deaths during the study period. Conclusions Countermeasures to COVID-19 did not affect treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. Data on the effect of countermeasures to COVID-19 on treatment outcomes should continue to be analyzed to ensure that treatment outcomes are not adversely affected.Ka-Won KangByung-Hyun LeeMin Ji JeonEun Sang YuDae Sik KimSe Ryeon LeeHwa Jung SungChul Won ChoiYong ParkByung Soo KimThe Korean Association of Internal Medicinearticletreatment outcomelymphomamultiple myelomacoronavirusMedicineRENThe Korean Journal of Internal Medicine, Vol 36, Iss 6, Pp 1459-1470 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
treatment outcome lymphoma multiple myeloma coronavirus Medicine R |
| spellingShingle |
treatment outcome lymphoma multiple myeloma coronavirus Medicine R Ka-Won Kang Byung-Hyun Lee Min Ji Jeon Eun Sang Yu Dae Sik Kim Se Ryeon Lee Hwa Jung Sung Chul Won Choi Yong Park Byung Soo Kim The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| description |
Background/Aims Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. We aimed to determine the effect of COVID-19 countermeasures on treatment outcomes in this patient population. Methods We retrospectively analyzed data on patients treated for lymphoma or multiple myeloma in two tertiary hospitals in Seoul. Patients were divided into two groups: group 1 included patients who received chemotherapy between September and December 2019 (the control period), and group 2 included patients who received chemotherapy between September and December 2020 (the study period). Countermeasures to COVID-19 were applied to the patients in group 2. The countermeasures implemented included mask wearing and regular handwashing at home and in hospital; COVID-19 risk assessments on all hospital visitors; and pre-emptive COVID-19 screening for all newly hospitalized patients and their resident guardians. Results No differences in treatment outcomes, including treatment response, incidence and duration of neutropenia or neutropenic fever, delays in chemotherapy, or number of deaths during chemotherapy, were observed between the g roups. None of the patients in group 2 tested positive for COVID-19, and there were no COVID-19-related deaths during the study period. Conclusions Countermeasures to COVID-19 did not affect treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. Data on the effect of countermeasures to COVID-19 on treatment outcomes should continue to be analyzed to ensure that treatment outcomes are not adversely affected. |
| format |
article |
| author |
Ka-Won Kang Byung-Hyun Lee Min Ji Jeon Eun Sang Yu Dae Sik Kim Se Ryeon Lee Hwa Jung Sung Chul Won Choi Yong Park Byung Soo Kim |
| author_facet |
Ka-Won Kang Byung-Hyun Lee Min Ji Jeon Eun Sang Yu Dae Sik Kim Se Ryeon Lee Hwa Jung Sung Chul Won Choi Yong Park Byung Soo Kim |
| author_sort |
Ka-Won Kang |
| title |
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| title_short |
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| title_full |
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| title_fullStr |
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| title_full_unstemmed |
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| title_sort |
effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma |
| publisher |
The Korean Association of Internal Medicine |
| publishDate |
2021 |
| url |
https://doaj.org/article/baa0bf3f9f8840cba3280b086bacb16c |
| work_keys_str_mv |
AT kawonkang theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT byunghyunlee theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT minjijeon theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT eunsangyu theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT daesikkim theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT seryeonlee theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT hwajungsung theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT chulwonchoi theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT yongpark theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT byungsookim theeffectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT kawonkang effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT byunghyunlee effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT minjijeon effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT eunsangyu effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT daesikkim effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT seryeonlee effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT hwajungsung effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT chulwonchoi effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT yongpark effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma AT byungsookim effectoftheresponsetothecoronavirusdiseasepandemicontreatmentoutcomesinpatientswithlymphomaandmultiplemyeloma |
| _version_ |
1718443309429424128 |